GridAI Technologies (GRDX) Enterprise Value (2015 - 2025)
GridAI Technologies' (GRDX) quarterly Enterprise Value came in at $4.2 million in Q4 2025, up 2685.24% YoY from $151737.3 in Q4 2024, and up 52.58% on a QoQ basis from $2.8 million in Q3 2025.
GridAI Technologies (GRDX) Enterprise Value (2015 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 11 years of Enterprise Value data on file, last reported at $4.2 million in Q4 2025.
- Quarterly Enterprise Value rose 2685.24% year-over-year to $4.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.2 million (up 2685.24% YoY) and the FY2025 annual result came in at $4.2 million, up 2685.24% from the prior year.
- Enterprise Value rose to $4.2 million in Q4 2025, from $2.8 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of $4.2 million in Q4 2025 to a low of -$12.0 million in Q1 2021.
- A 5-year average of -$2.7 million and a median of -$1.6 million in 2022 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2021 — Enterprise Value tumbled 719.79% — and 2025, when it jumped 2685.24%.
- Tracing GRDX's Enterprise Value over 5 years: stood at -$8.2 million in 2021, then soared by 82.97% to -$1.4 million in 2022, then slumped by 167.39% to -$3.8 million in 2023, then jumped by 95.65% to -$163476.0 in 2024, then jumped by 2685.24% to $4.2 million in 2025.
- The last three Enterprise Value figures came in at $4.2 million (Q4 2025), $2.8 million (Q3 2025), and -$8948.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.90 Bn | 132.05 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 65.73 Bn | 60.55 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 58.33 Bn | 53.19 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.72 Bn | 28.42 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 28.27 Bn | 9.88 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.25 Bn | 26.41 Bn | - | 2.12 Bn |
| 10 | GridAI Technologies | 6.26 Mn | 6.26 Mn | - | 4.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.23 Mn |
| Sep 30, 2025 | 2.77 Mn |
| Jun 30, 2025 | -8,948.00 |
| Mar 31, 2025 | -73,000.00 |
| Dec 31, 2024 | -163,476.00 |
| Sep 30, 2024 | -408,308.00 |
| Jun 30, 2024 | -703,995.00 |
| Mar 31, 2024 | -3.47 Mn |
| Dec 31, 2023 | -3.76 Mn |
| Sep 30, 2023 | -3.33 Mn |
| Jun 30, 2023 | -1.28 Mn |
| Mar 31, 2023 | -2.11 Mn |
| Dec 31, 2022 | -1.40 Mn |
| Sep 30, 2022 | -1.70 Mn |
| Jun 30, 2022 | -1.16 Mn |
| Mar 31, 2022 | -5.69 Mn |
| Dec 31, 2021 | -8.25 Mn |
| Sep 30, 2021 | -7.21 Mn |
| Jun 30, 2021 | -8.07 Mn |
| Mar 31, 2021 | -12.03 Mn |